Bedfont chosen as a Technology Business finalist for the 10th National Family Business Awards
Medical device manufacturer, Bedfont Scientific Ltd., reaches the Family Business Awards finals for the Technology category
By: Bedfont Scientific Ltd.
Established in 1976, Bedfont specialises in the design and manufacture of innovative breath analysis medical devices. Its breath analysers include carbon monoxide (CO) monitors such as the Smokerlyzer, used for smoking cessation, and the ToxCO, used by emergency services, to screen for CO poisoning. The NObreath FeNO monitor provides accurate analysis of airway inflammation for the control of asthma, and the Gastrolyzer range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.
Amalia Brightley-Gillott, Managing Director of Family Business Place, who hosts the awards, says, "We're over the moon to welcome Bedfont as Finalists at this year's awards. They're an exceptional example of how family businesses are leading the way, continuing to innovate and thriving in today's competitive, economically uncertain world."
Jason Smith, Managing Director, comments, "Becoming a 2nd generation family business has reinforced our family values and enabled us to create a strong sense of identity and culture for the business as the Bedfont Family. Strong family values can prove instrumental in stabilising the structure and dynamics within the business resulting in high employee sense of belonging and satisfaction thus increasing productivity, loyalty and profitability. Breath analysis for medical applications is a very niche technology and we are thrilled to be recognised for our contribution to healthcare, by being chosen as a finalist in the Family Business Awards for the Technology category."
The winners will be announced at Wembley Stadium on 13th July in what's set to be a spectacular 10th anniversary celebration of the awards.